Acarbose ameliorates Western diet-induced metabolic and cognitive impairments in the 3xTg mouse model of Alzheimer’s disease
GeroScience · 14.09.2024 · 47 (2) · 1569-1591
DOI: 10.1007/s11357-024-01337-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift GeroScience, online erschienen am 14.09.2024. Verfasst von Michelle M Sonsalla und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA. Hauptthemen laut MEDLINE: Acarbose, Alzheimer Disease, Diet, Western, Cognitive Dysfunction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, BLRD VA, NCI NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Age is the greatest risk factor for Alzheimer's disease (AD) as well as for other disorders that increase the risk of AD such as diabetes and obesity. There is growing interest in determining if interventions that promote metabolic health can prevent or delay AD. Acarbose is an anti-diabetic drug that not only improves glucose homeostasis, but also extends the lifespan of wild-type mice. Here, we test the hypothesis that acarbose will not only preserve metabolic health, but also slow or prevent AD pathology and cognitive deficits in 3xTg mice, a model of AD, fed either a Control diet or a high-fat, high-sucrose Western diet (WD). We find that acarbose decreases the body weight and adiposity of WD-fed 3xTg mice, increasing energy expenditure while also stimulating food consumption, and improves glycemic control. Both male and female WD-fed 3xTg mice have worsened cognitive deficits than Control-fed mice, and these deficits are ameliorated by acarbose treatment. Molecular and histological analysis of tau and amyloid pathology identified sex-specific effects of acarbose which are uncoupled from the dramatic improvements in cognition in females, suggesting that the benefits of acarbose on AD may be largely driven by improved metabolic health. In conclusion, our results suggest that acarbose may be a promising intervention to prevent, delay, or even treat AD, especially in individuals consuming a WD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Wisconsin-Madison, 1685 Highland Ave, MFCB Rm 4147, Madison, WI, 53705, USA.
- William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.
- Comparative Biomedical Sciences, University of Wisconsin-Madison, Madison, WI, USA.
- Cellular and Molecular Biology Graduate Program, University of Wisconsin-Madison, Madison, WI, USA.
- Endocrinology and Reproductive Physiology Program, University of Wisconsin-Madison, Madison, WI, USA.
- Nutrition and Metabolism Graduate Program, University of Wisconsin-Madison, Madison, WI, USA.
ORCID-Profile: Dudley W Lamming
Förderung
- NIA NIH HHS
- BLRD VA
- NCI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
Zitieren
APA
Sonsalla, M. M., Babygirija, R., Johnson, M., Cai, S., Cole, M., Yeh, C. Y., Grunow, I., Liu, Y., Vertein, D., Calubag, M. F., Trautman, M. E., Green, C. L., Rigby, M. J., Puglielli, L., & Lamming, D. W. (2024). Acarbose ameliorates Western diet-induced metabolic and cognitive impairments in the 3xTg mouse model of Alzheimer’s disease. GeroScience, 47(2), 1569-1591. https://doi.org/10.1007/s11357-024-01337-3
Vancouver
Sonsalla MM, Babygirija R, Johnson M, Cai S, Cole M, Yeh CY, et al. Acarbose ameliorates Western diet-induced metabolic and cognitive impairments in the 3xTg mouse model of Alzheimer’s disease. GeroScience. 2024;47(2):1569-1591. doi:10.1007/s11357-024-01337-3
BibTeX
@article{Sonsalla2024,
author = {Sonsalla, Michelle M and Babygirija, Reji and Johnson, Madeline and Cai, Samuel and Cole, Mari and Yeh, Chung-Yang and Grunow, Isaac and Liu, Yang and Vertein, Diana and Calubag, Mariah F and Trautman, Michaela E and Green, Cara L and Rigby, Michael J and Puglielli, Luigi and Lamming, Dudley W},
title = {Acarbose ameliorates Western diet-induced metabolic and cognitive impairments in the 3xTg mouse model of Alzheimer’s disease},
journal = {GeroScience},
year = {2024},
volume = {47},
number = {2},
pages = {1569--1591},
doi = {10.1007/s11357-024-01337-3}
}
EUVIMED